{"nctId":"NCT01927497","briefTitle":"Biological Mesh Closure of the Pelvic Floor After Extralevator Abdomino Perineal Resection for Rectal Cancer","startDateStruct":{"date":"2013-03-08","type":"ACTUAL"},"conditions":["Rectal Cancer"],"count":104,"armGroups":[{"label":"Biological mesh closure","type":"EXPERIMENTAL","interventionNames":["Procedure: Biological mesh assisted perineal closure"]},{"label":"Primary perineal closure","type":"ACTIVE_COMPARATOR","interventionNames":["Procedure: Primary perineal closure"]}],"interventions":[{"name":"Biological mesh assisted perineal closure","otherNames":["Biological Mesh","Strattice™","Strattice® Reconstructive Tissue Matrix","Lifecell","Porcine dermal Mesh"]},{"name":"Primary perineal closure","otherNames":["Primary closure","Perineal wound closure"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Age of 18 years or higher.\n2. Planned for eAPR for primary rectal cancer.\n3. Life expectancy of more than 2 years.\n4. Ability to return for all scheduled and required study visits.\n5. Preoperative (chemo)radiotherapy.\n6. Written informed consent for study participation.\n\nExclusion Criteria:\n\n1. Previous pelvic irradiation for other cancers (i.e. prostate cancer).\n2. Total exenteration or sacral resection above level S4/S5.\n3. Sensitivity to porcine derived products or polysorbate.\n4. Severe systemic diseases affecting wound healing (i.e. renal failure requiring dialysis, liver cirrhosis, and immune compromised status like HIV).\n5. Collagen disorders (i.e. Marfan).\n6. Enrolment in trials with overlapping primary endpoint or otherwise expected influence on wound healing (i.e. biological therapy like antiangiogenic agents).","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"30-day Uncomplicated Perineal Wound Healing","description":"uncomplicated perineal wound healing is defined as a Souphampton wound score less than II","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"30","spread":null},{"groupId":"OG001","value":"33","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":20,"n":48},"commonTop":["surgical complication"]}}}